North Carolina Product Liability Lawyer Blog

Articles Tagged with Ozempic and DVT

Are Ozempic Users at an Increased Risk of Deep Vein Thrombosis (DVT)?

Published on: February 5, 2025 | By Clay Hodges

Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) that works by mimicking a hormone that the body uses to signal that it’s full or satisfied. It was originally approved for treating type 2 diabetes (under the Ozempic brand name), but the U.S. Food and Drug Administration soon approved it to help patients lose weight (under the Wegovy brand name).

Ozempic and Wegovy have received considerable attention for various reasons, including their side effects. I’ve discussed some of these in earlier blog posts about gastroparesis and vision problems, like NAION. Unfortunately, additional serious side effects continue to be brought up, including complications from blood clots, such as deep vein thrombosis (DVT). Let’s take a closer look at semaglutide and its connection to DVT.

What Is Deep Vein Thrombosis?

Initial Consultation919-546-8788

★★★★★

I was involved in a case for the faulty hip replacements. Clay Hodges represented me. I can't say enough about how much he has helped me. Clay was able to win multiple settlements on my behalf with most of them being the maximum amount able to be awarded. Matt J.

★★★★★

Clay, thank you sir for making a disheartening experience at least palatable, you and your staff were honest, caring and understanding through the entire process of my wife’s hip replacements, while monetary settlements never make the pain and suffering end, it sometimes is the only way people can fight back to right a wrong. J. V.

★★★★★

We are absolutely pleased with how Clay Hodges handled my husband’s hip replacement claim. He always kept us informed of the progress. And, his work resulted in a settlement which we are extremely pleased. Thank you, Clay! Carol L. & Norm L.